[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Thu, Sep 01st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Wed, Aug 31st 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
[ Tue, Aug 30th 2022 ]: WOPRAI
David Amsellem Maintained (SUPN) at Buy with Increased Target to $38 on, Aug 31st, 2022
- 🞛 This publication is a summary or evaluation of another publication
David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Increased Target from $33 to $38 on, Aug 31st, 2022.
David, nor any peers, have made any analyst calls on SUPN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30